Status:
UNKNOWN
European Quality Improvement Programme for Acute Coronary Syndromes
Lead Sponsor:
Royal Brompton & Harefield NHS Foundation Trust
Collaborating Sponsors:
Uppsala University
GlaxoSmithKline
Conditions:
Acute Coronary Syndrome
Eligibility:
All Genders
Up to 80 years
Phase:
NA
Brief Summary
The main hypothesis to be tested is that the use of a quality improvement programme will lead to measurable improvements in the management of care and use of evidence based treatments for patients pre...
Eligibility Criteria
Inclusion
- Patients with a good clinical history of ACS and at least one of the following:
- New or transient ST or T wave changes on the ECG consistent with acute myocardial ischaemia
- Elevation of troponin or other cardiac markers to levels indicative of myocardial necrosis according to local laboratory values
Exclusion
- Evidence of persistent ST elevation on the ECG
- Use of early reperfusion therapy
- Patients \>80 years
- Patients transferred from another hospital
Key Trial Info
Start Date :
August 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2009
Estimated Enrollment :
3500 Patients enrolled
Trial Details
Trial ID
NCT00716430
Start Date
August 1 2007
End Date
February 1 2009
Last Update
July 16 2008
Active Locations (37)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de la region d'Annecy
Annecy, France
2
Centre Hospitalier de Chambery
Chambéry, France
3
Cardiology dept. B, CHU Hopital G. Montpied
Clermont-Ferrand, France
4
CHU de Grenoble
Grenoble, France